🔗 Permalink

Inventor profile of:

Lawrence R. McGee

City:

Pacifica, California

Country:

United States

Published Applications:

Last publication date:

2026-03-19

Top Assignees for applications by Lawrence R. McGee

The entities that hold a legal rights for patent applications filed by inventor McGee Lawrence R.:

Amgen Inc. 43 Thousand Oaks, CA United States
ORIC PHARMACEUTICALS, INC. 5 South San Francisco, CA United States
AMGEN IINC. 1 Thousand Oaks, CA United States
Gilead Sciences, Inc. 1 Foster City, CA United States
Japan Tobacco, Inc. 1 Osaka, Japan
Amgen Inc. 1 South San Francisco, CA United States
JAPAN TOBACCO INC. 1 Tokyo, Japan

Recent patent applications by McGee Lawrence R.

Lawrence R. McGee from Pacifica, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-19

US20260078091A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#2 | 2025-09-25

US20250295647A1

Human necessities

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

#3 | 2024-09-12

US20240300892A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#4 | 2023-09-28

US20230301974A1

Human necessities

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

#5 | 2023-03-30

US20230096870A1

Chemistry; metallurgy

INHIBITORS OF GLUCOCORTICOID RECEPTOR

#6 | 2022-09-08

US20220280496A1

Human necessities

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

#7 | 2022-06-02

US20220169611A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#8 | 2021-12-23

US20210395295A1

Chemistry; metallurgy

INHIBITORS OF GLUCOCORTICOID RECEPTOR

#9 | 2021-12-09

US20210379084A1

Human necessities

INHIBITORS OF GLUCOCORTICOID RECEPTOR

#10 | 2021-06-17

US20210179560A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#11 | 2021-01-28

US20210023095A1

Human necessities

Inhibitors of glucocorticoid receptor

#12 | 2021-01-21

US20210017220A1

Chemistry; metallurgy

Inhibitors of glucocorticoid receptor

#13 | 2021-01-21

US20210017219A1

Chemistry; metallurgy

INHIBITORS OF GLUCOCORTICOID RECEPTOR

#14 | 2021-01-07

US20210002324A1

Chemistry; metallurgy

Inhibitors of glucocorticoid receptor

#15 | 2020-09-17

US20200291058A1

Chemistry; metallurgy

Inhibitors of glucocorticoid receptor

#16 | 2020-09-10

US20200281912A1

Human necessities

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

#17 | 2020-02-13

US20200048265A1

Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS AND THEIR USES

#18 | 2019-07-18

US20190218246A1

Chemistry; metallurgy

Inhibitors of glucocorticoid receptor

#19 | 2019-02-28

US20190062276A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#20 | 2018-11-08

US20180319773A1

Chemistry; metallurgy

Triazole agonists of the APJ receptor

#21 | 2018-04-19

US20180105532A1

Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS AND THEIR USES

#22 | 2018-04-05

US20180092898A1

Human necessities

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

#23 | 2018-03-29

US20180087079A1

Chemistry; metallurgy

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE

#24 | 2017-05-25

US20170144971A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#25 | 2017-02-16

US20170044131A1

Chemistry; metallurgy

Methods for preparing triazole agonists of the APJ receptor

#26 | 2017-02-16

US20170042897A1

Human necessities

Intermediates for preparing triazole agonists of the APJ receptor

#27 | 2017-02-16

US20170042872A1

Human necessities

Triazole agonists of the APJ receptor

#28 | 2017-02-16

US20170042871A1

Human necessities

Triazole agonists of the APJ receptor

#29 | 2017-02-09

US20170037026A1

Chemistry; metallurgy

Triazole agonists of the APJ receptor

#30 | 2017-02-09

US20170035744A1

Human necessities

Intermediates for preparing triazole agonists of the APJ receptor

#31 | 2016-12-22

US20160368933A1

Chemistry; metallurgy

FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3

#32 | 2016-11-24

US20160340336A1

Chemistry; metallurgy

Triazole agonists of the APJ receptor

#33 | 2016-10-06

US20160289243A1

Chemistry; metallurgy

Processes of making and crystalline forms of a MDM2 inhibitor

#34 | 2016-10-06

US20160289190A1

Chemistry; metallurgy

Processes of making and crystalline forms of a MDM2 inhibitor

#35 | 2016-05-19

US20160137667A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#36 | 2015-12-10

US20150353542A1

Chemistry; metallurgy

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE

#37 | 2015-02-12

US20150045361A1

Chemistry; metallurgy

Heterocyclic compounds and their uses

#38 | 2014-12-11

US20140364455A1

Chemistry; metallurgy

Processes of making and crystalline forms of a MDM2 inhibitor

#39 | 2014-11-27

US20140350244A1

Chemistry; metallurgy

Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors

#40 | 2014-10-23

US20140315895A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#41 | 2014-07-17

US20140199728A1

Chemistry; metallurgy

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE

#42 | 2014-06-12

US20140163052A1

Chemistry; metallurgy

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3

#43 | 2014-01-09

US20140011796A1

Chemistry; metallurgy

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

#44 | 2012-09-27

US20120244110A1

Chemistry; metallurgy

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3

#45 | 2012-08-30

US20120220586A1

Chemistry; metallurgy

Heterocyclic compounds and their uses

#46 | 2012-08-30

US20120220585A1

Chemistry; metallurgy

Heterocyclic compounds and their uses

#47 | 2011-06-16

US20110142796A1

Chemistry; metallurgy

Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors

#48 | 2011-04-28

US20110097305A1

Chemistry; metallurgy

Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors

#49 | 2011-04-14

US20110086834A1

Chemistry; metallurgy

ALKYNYL ALCOHOLS AS KINASE INHIBITORS

#50 | 2010-05-06

US20100113522A1

Chemistry; metallurgy

Compounds for the modulation of PPARγ activity

#51 | 2009-12-01

US10810325

Compounds for the modulation of PPARγ activity

#52 | 2009-10-13

US10719997

Quinolinyl and benzothiazolyl modulators

#53 | 2009-09-03

US20090221635A1

Chemistry; metallurgy

Quinolinyl and benzothiazolyl modulators

#54 | 2009-09-03

US20090221584A1

Chemistry; metallurgy

Bisaryl-sulfonamides

#55 | 2009-05-28

US20090137581A1

Chemistry; metallurgy

Heterocyclic compounds and their uses

#56 | 2008-10-21

US10882022

Nucleotide analogs

#57 | 2008-10-21

US10123298

PPARγ modulators

#58 | 2007-12-20

US20070293536A1

Chemistry; metallurgy

Salts and polymorphs of a potent antidiabetic compound

#59 | 2006-05-09

US9606433

Compounds for the modulation of PPARγ activity

#60 | 2006-04-20

US20060084802A1

Chemistry; metallurgy

Bisaryl-sulfonamides

#61 | 2005-06-30

US20050143416A1

Chemistry; metallurgy

Salts and polymorphs of a potent antidiabetic compound

InventorID:

606422 ⎘